DiamondTemp Global Registry

Launched by MEDTRONIC CARDIAC ABLATION SOLUTIONS · Jan 28, 2021

Keywords

ClinConnect Summary

The DiamondTemp Global Registry is a research study that looks at the use of a special medical device called the DiamondTemp™ Ablation System, which helps treat a heart condition known as arrhythmia. This study is open to people aged 18 and older who are planning to undergo a procedure with this device. If you decide to participate, you'll be asked to agree to the study rules and share information about your experience.

As a participant, you can expect to be part of a global effort to understand how well the DiamondTemp system works in treating arrhythmias. It’s important to know that this study is currently recruiting participants, and it welcomes individuals of any gender. However, if you are already part of another study or have specific local legal restrictions, you may not be able to join this one. Your involvement will contribute to valuable insights that could help improve treatment for others in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Subject is ≥ 18 years of age or minimum age as required by local regulations
• • Planned procedure using commercially available DiamondTemp™ Ablation System
• • Willing to comply with study requirements and give IC (defined as legally effective, documented confirmation of a subject's voluntary agreement to participate in this clinical study) or authorization per institution and geographical requirements
• Exclusion Criteria:
• • Subject is enrolled in a concurrent study that has not been approved for concurrent enrollment by the global study manager
• • Subject with exclusion criteria required by local law